menu search

OPT / Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MD

Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MD
MELBOURNE, Australia, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announce that MST Access will host an “Ask the Expert” conference call with Professor Jason S. Slakter, M.D. on Tuesday 13th December 6:30pm – 7:30pm EST USA (Wednesday 14th December 10:30am – 11:30am AEDT). Read More
Posted: Dec 12 2022, 10:08
Author Name: GlobeNewsWire
Views: 102471

OPT News  

Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference

By GlobeNewsWire
October 30, 2023

Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference

MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing no more_horizontal

Opthea to Present at the 2023 Ophthalmology Innovation Summit

By GlobeNewsWire
July 24, 2023

Opthea to Present at the 2023 Ophthalmology Innovation Summit

MELBOURNE, Australia, July 24, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing no more_horizontal

Opthea To Present at the JMP Securities Life Sciences Conference

By GlobeNewsWire
May 8, 2023

Opthea To Present at the JMP Securities Life Sciences Conference

MELBOURNE, Australia, May 08, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing nov more_horizontal

Opthea To Present at Sequire Biotechnology Conference

By GlobeNewsWire
January 30, 2023

Opthea To Present at Sequire Biotechnology Conference

MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing no more_horizontal

Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MD

By GlobeNewsWire
December 12, 2022

Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MD

MELBOURNE, Australia, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing no more_horizontal

Opthea to Present at the FLORetina 2022 Congress

By GlobeNewsWire
December 6, 2022

Opthea to Present at the FLORetina 2022 Congress

MELBOURNE, Australia, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing no more_horizontal

Optiva Inc. (RKNEF) Q3 2022 Earnings Call Transcript

By Seeking Alpha
November 12, 2022

Optiva Inc. (RKNEF) Q3 2022 Earnings Call Transcript

Optiva Inc. (OTCPK:RKNEF) Q3 2022 Results Conference Call November 9, 2022 8:30 AM ET Company Participants Ali Mahdavi - Investor Relations John Giere more_horizontal


Search within

Pages Search Results: